Molecular Genetics and Epidemiology of Prostate Carcinoma
Emiel Ruijter,
Christina van de Kaa,
Gary Miller,
Dirk Ruiter,
Frans Debruyne and
Jack Schalken
Departments of Urology (E.R., F.D., J.S.) and Pathology (E.R.,
C.v.d.K., D.R.), University Hospital Nijmegen, 6500 HB, Nijmegen, The
Netherlands; Department of Pathology (G.M.), University of Colorado,
Health Sciences Center, Denver, Colorado 80260, U.S.A.; and Department
of Pathology and Companion Animals (J.S.), Veterinarian Faculty,
University of Utrecht, 3508 TD, Utrecht, The Netherlands
I. Introduction
A. Prostate carcinoma epidemiology: mortalityrates, incidence,and
prevalence
B. Familial clustering ofprostate carcinoma
C. Scope of the review
II. Somatic GeneticAlterations in Prostate Carcinoma
A. Alterations in DNA methylation
B. The androgen signaling cascade
C. Vitamin D and prostatecarcinoma
D. Oncogenes
E. TSGs
F. Metastasis suppressorgenes (MSGs)
G. Telomerase activity
III. Etiology of FamilialClustering of Prostate Carcinoma
IV. Human Papillomavirusand Prostate Carcinoma
V. Morphological Diversity of ProstateCarcinoma
VI. Concluding Remarks
This article has been cited by other articles:
P. Tuohimaa, L. Tenkanen, H. Syvala, S. Lumme, T. Hakulinen, J. Dillner, and M. Hakama Interaction of Factors Related to the Metabolic Syndrome and Vitamin D on Risk of Prostate Cancer
Cancer Epidemiol. Biomarkers Prev.,
February 1, 2007;
16(2):
302 - 307.
[Abstract][Full Text][PDF]
N. Z. Lu, S. E. Wardell, K. L. Burnstein, D. Defranco, P. J. Fuller, V. Giguere, R. B. Hochberg, L. McKay, J.-M. Renoir, N. L. Weigel, et al. International Union of Pharmacology. LXV. The Pharmacology and Classification of the Nuclear Receptor Superfamily: Glucocorticoid, Mineralocorticoid, Progesterone, and Androgen Receptors
Pharmacol. Rev.,
December 1, 2006;
58(4):
782 - 797.
[Full Text][PDF]
J. Duff and I. J. McEwan Mutation of Histidine 874 in the Androgen Receptor Ligand-Binding Domain Leads to Promiscuous Ligand Activation and Altered p160 Coactivator Interactions
Mol. Endocrinol.,
December 1, 2005;
19(12):
2943 - 2954.
[Abstract][Full Text][PDF]
J. C. Hsu, J. Zhang, A. Dev, A. Wing, L. F. Bjeldanes, and G. L. Firestone Indole-3-carbinol inhibition of androgen receptor expression and downregulation of androgen responsiveness in human prostate cancer cells
Carcinogenesis,
November 1, 2005;
26(11):
1896 - 1904.
[Abstract][Full Text][PDF]
K-M Rau, H-Y Kang, T-L Cha, S A Miller, and M-C Hung The mechanisms and managements of hormone-therapy resistance in breast and prostate cancers
Endocr. Relat. Cancer,
September 1, 2005;
12(3):
511 - 532.
[Abstract][Full Text][PDF]
E. Nieschlag, H.M. Behre, P. Bouchard, J.J. Corrales, T.H. Jones, G.K. Stalla, S.M. Webb, and F.C.W. Wu Testosterone replacement therapy: current trends and future directions
Hum. Reprod. Update,
September 1, 2004;
10(5):
409 - 419.
[Abstract][Full Text][PDF]
G. Ayala, D. Wang, G. Wulf, A. Frolov, R. Li, J. Sowadski, T. M. Wheeler, K. P. Lu, and L. Bao The Prolyl Isomerase Pin1 Is a Novel Prognostic Marker in Human Prostate Cancer
Cancer Res.,
October 1, 2003;
63(19):
6244 - 6251.
[Abstract][Full Text][PDF]
C. Ntais, A. Polycarpou, and J. P. A. Ioannidis SRD5A2 Gene Polymorphisms and the Risk of Prostate Cancer: A Meta-Analysis
Cancer Epidemiol. Biomarkers Prev.,
July 1, 2003;
12(7):
618 - 624.
[Abstract][Full Text][PDF]
S. B. Shappell, S. J. Olson, S. E. Hannah, S. Manning, R. L. Roberts, N. Masumori, M. Jisaka, W. E. Boeglin, V. Vader, D. S. Dave, et al. Elevated Expression of 12/15-Lipoxygenase and Cyclooxygenase-2 in a Transgenic Mouse Model of Prostate Carcinoma
Cancer Res.,
May 1, 2003;
63(9):
2256 - 2267.
[Abstract][Full Text][PDF]
P. Harkonen, S. Torn, R. Kurkela, K. Porvari, A. Pulkka, A. Lindfors, V. Isomaa, and P. Vihko Sex Hormone Metabolism in Prostate Cancer Cells during Transition to an Androgen-Independent State
J. Clin. Endocrinol. Metab.,
February 1, 2003;
88(2):
705 - 712.
[Abstract][Full Text][PDF]
W. Xin, D. R. Rhodes, C. Ingold, A. M. Chinnaiyan, and M. A. Rubin Dysregulation of the Annexin Family Protein Family Is Associated with Prostate Cancer Progression
Am. J. Pathol.,
January 1, 2003;
162(1):
255 - 261.
[Abstract][Full Text][PDF]
G. Untergasser, H. B. Koch, A. Menssen, and H. Hermeking Characterization of Epithelial Senescence by Serial Analysis of Gene Expression: Identification of Genes Potentially Involved in Prostate Cancer
Cancer Res.,
November 1, 2002;
62(21):
6255 - 6262.
[Abstract][Full Text][PDF]
J. Huang, W. C. Powell, A. C. Khodavirdi, J. Wu, T. Makita, R. D. Cardiff, M. B. Cohen, H. M. Sucov, and P. Roy-Burman Prostatic Intraepithelial Neoplasia in Mice with Conditional Disruption of the Retinoid X Receptor{alpha} Allele in the Prostate Epithelium
Cancer Res.,
August 15, 2002;
62(16):
4812 - 4819.
[Abstract][Full Text][PDF]
M. A. Rubin, M. Zhou, S. M. Dhanasekaran, S. Varambally, T. R. Barrette, M. G. Sanda, K. J. Pienta, D. Ghosh, and A. M. Chinnaiyan {alpha}-Methylacyl Coenzyme A Racemase as a Tissue Biomarker for Prostate Cancer
JAMA,
April 3, 2002;
287(13):
1662 - 1670.
[Abstract][Full Text][PDF]
H. Miyamoto, M. Rahman, H. Takatera, H.-Y. Kang, S. Yeh, H.-C. Chang, K. Nishimura, N. Fujimoto, and C. Chang A Dominant-negative Mutant of Androgen Receptor Coregulator ARA54 Inhibits Androgen Receptor-mediated Prostate Cancer Growth
J. Biol. Chem.,
February 8, 2002;
277(7):
4609 - 4617.
[Abstract][Full Text][PDF]
N. Dejucq and B. Jegou Viruses in the Mammalian Male Genital Tract and Their Effects on the Reproductive System
Microbiol. Mol. Biol. Rev.,
June 1, 2001;
65(2):
208 - 231.
[Abstract][Full Text][PDF]
R. Montironi, R. Mazzucchelli, F. Algaba, and A. Lopez-Beltran Morphological identification of the patterns of prostatic intraepithelial neoplasia and their importance
J. Clin. Pathol.,
September 1, 2000;
53(9):
655 - 665.
[Abstract][Full Text][PDF]
D. Feldman, X.-Y. Zhao, and A. V. Krishnan Editorial/Mini-Review: Vitamin D and Prostate Cancer
Endocrinology,
January 1, 2000;
141(1):
5 - 9.
[Full Text][PDF]
M. Marcelli and G. R. Cunningham Hormonal Signaling in Prostatic Hyperplasia and Neoplasia
J. Clin. Endocrinol. Metab.,
October 1, 1999;
84(10):
3463 - 3468.
[Full Text][PDF]